-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下:我们维持“买入”评级,基于其估值(截至4月30日,该股目前的市盈率较历史平均水平折让24%)以及在新兴市场(印度)的增长前景和水处理业务扩张方面的布局。同时,我们维持87美元的目标价,基于19.5倍的2027年预期市盈率,高于五年平均水平18.6倍,主要得益于销售额/利润率的增长和新产品的推出。AOS公布了令人失望的2026财年第一季度业绩,销售额同比下降2%至9.456亿美元,稀释后每股收益下降11%至0.85美元,低于市场普遍预期的0.94美元。该季度业绩受到中国市场持续疲软、北美住宅热水器需求下降以及天气相关干扰的影响。公司下调了2026财年的业绩预期。然而,我们预计2027财年暂不会受到影响。我们将2026年每股收益预期从4.15美元下调至3.85美元,2027年维持4.47美元的预期不变。
Related Articles
Market Chatter: Coles CEO Says Grocery Price Increases 'Inevitable' Amid Fuel Cost Surge
Coles Group (ASX:COL) Chief Executive Leah Weckert said price hikes for groceries are "inevitable" as the supermarket chain and its suppliers deal with higher fuel costs, Bloomberg reported Monday.Speaking at an Australian Shareholders' Association conference in Melbourne, Weckert said that the trend is showing up in supermarket data, with shoppers opting for beef mince or chicken over steak, while also making fewer trips to stores to cut fuel costs.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Singapore Airlines to Deploy Starlink Broadband Services in 2027
Singapore Airlines (SGX:C6L) will deploy Starlink's low-earth-orbit satellite-based broadband service on its planes, starting from the first quarter of 2027, according to a company release on Monday.The service will be available to all cabin classes on Starlink-enabled aircraft.
iX Biopharma Secures Listing and Quotation Notice for New Shares; Shares Zoom 11%
iX Biopharma (SGX:42C) received a listing and quotation notice from the Singapore Exchange Securities Trading for 1.3 million shares, according to a Thursday filing with the Singapore Exchange.Shares of the pharmaceutical and nutraceutical company surged nearly 11% in Monday trading.The notice is subject to shareholder approval and compliance with the bourse's listing requirements, the filing added.